evidence table
L-Citrulline Blood Pressure Randomized Trial Evidence Table
Structured evidence table for L-Citrulline Blood Pressure Randomized Trial, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| L-Citrulline Blood Pressure Randomized Trial | Background Postmenopausal women are at increased risk of developing cardiovascular, muscular, and metabolic dysfunction due to hormonal changes associated with aging. | 1 | Bahari H (2026) | Citrulline supplementation in postmenopausal women: a systematic review of vascular, muscular, and metabolic effects. |
| L-Citrulline Blood Pressure Randomized Trial | Conclusion Citrulline supplementation may offer benefits for blood pressure regulation (up to 9 mmHg SBP reduction in some studies) in hypertensive postmenopausal women, but evidence for arterial stiffness, endothelial function, and metabolic outcomes remains inconsistent. | 1 | Bahari H (2026) | Citrulline supplementation in postmenopausal women: a systematic review of vascular, muscular, and metabolic effects. |
| L-Citrulline Blood Pressure Randomized Trial | Citrulline, a non-essential amino acid and precursor to nitric oxide, has gained interest as a potential dietary supplement for improving vascular health, muscle function, and metabolic parameters in this population. | 1 | Bahari H (2026) | Citrulline supplementation in postmenopausal women: a systematic review of vascular, muscular, and metabolic effects. |
Source documents